MoonLake Return On Tangible Assets from 2010 to 2024

MLTX Stock  USD 54.68  0.44  0.81%   
MoonLake Immunotherapeuti Return On Tangible Assets yearly trend continues to be fairly stable with very little volatility. Return On Tangible Assets will likely drop to -0.07 in 2024. Return On Tangible Assets is a profitability metric that measures a company's ability to generate earnings from its tangible assets. View All Fundamentals
 
Return On Tangible Assets  
First Reported
2010-12-31
Previous Quarter
(0.07)
Current Value
(0.07)
Quarterly Volatility
1.42848387
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MoonLake Immunotherapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MoonLake Immunotherapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.5 K, Other Operating Expenses of 34.1 M or Total Operating Expenses of 34.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.28. MoonLake financial statements analysis is a perfect complement when working with MoonLake Immunotherapeuti Valuation or Volatility modules.
  
Check out the analysis of MoonLake Immunotherapeuti Correlation against competitors.

Latest MoonLake Immunotherapeuti's Return On Tangible Assets Growth Pattern

Below is the plot of the Return On Tangible Assets of MoonLake Immunotherapeutics over the last few years. It is a profitability metric that measures a company's ability to generate earnings from its tangible assets. MoonLake Immunotherapeuti's Return On Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MoonLake Immunotherapeuti's overall financial position and show how it may be relating to other accounts over time.
Return On Tangible Assets10 Years Trend
Slightly volatile
   Return On Tangible Assets   
       Timeline  

MoonLake Return On Tangible Assets Regression Statistics

Arithmetic Mean(0.44)
Coefficient Of Variation(328.21)
Mean Deviation0.73
Median(0.0008)
Standard Deviation1.43
Sample Variance2.04
Range5.5395
R-Value(0.30)
Mean Square Error1.99
R-Squared0.09
Significance0.27
Slope(0.1)
Total Sum of Squares28.57

MoonLake Return On Tangible Assets History

2024 -0.0718
2023 -0.0684
2022 -0.84
2021 -5.54

About MoonLake Immunotherapeuti Financial Statements

MoonLake Immunotherapeuti investors use historical fundamental indicators, such as MoonLake Immunotherapeuti's Return On Tangible Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MoonLake Immunotherapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.07)(0.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.